Application and problem analysis of traditional Chinese medicine in the treatment of coronavirus disease 19
Northwest Pharmaceutical Journal
; 36(6):1027-1033, 2021.
Article
in Chinese
| CAB Abstracts | ID: covidwho-1905432
Non-food/Non-feed Plant Products [SS200]; Animal and in vitro Models for Pharmaceuticals [VV450]; Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Pesticides and Drugs; Control [HH405]; herbal drugs; medicinal plants; coronavirus disease 2019; viral diseases; human diseases; traditional Chinese medicines; reviews; flavonoids; quercetin; kaempferol; enzymes; mitogen-activated protein kinase; interleukin 6; man; Severe acute respiratory syndrome coronavirus 2; plants; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; prostaglandin-endoperoxide synthase; herbal medicines; drug plants; medicinal herbs; officinal plants; SARS-CoV-2; viral infections
Search on Google
Collection:
Databases of international organizations
Database:
CAB Abstracts
Topics:
Traditional medicine
Language:
Chinese
Journal:
Northwest Pharmaceutical Journal
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS